2017 Annual Meeting

Session: Diagnostics, Treatments and Theranostics

This session explores the contributions of chemical engineers to the development and commercialization of treatments, diagnostics and theranostics. Contributions from image contrast agents to the design of new medicines welcome.

Chair

Hedieh Saffari, University of Utah

Co-Chair

Huanan Zhang, University of Utah

Presentations

12:30 PM

(541a) Protein and Gold Nanoparticle Based Radiation Sensor
Amar Thaker, Brent L. Nannenga, Karthik Pushpavanam, Kaushal Rege

12:55 PM

(541b) Direct Detection of Nucleic Acids without Amplification
Zachary McGee, Savannah Dewberry, Carter Wright, Paula Koelle, Peggy Sammon, Krishnan Chittur

01:20 PM

(541c) Photoacoustic Imaging to Simultaneously Detect the Accumulation of Multiple Contrast Agents within Tumors
Leon Z. Wang, Hoang D. Lu, Tristan L. Lim, Brian K. Wilson, Andrew Heinmiller, Robert K. Prud'homme

01:45 PM

(541d) DNA Methylation Detection with an Engineered Protein That Binds Hemi-Methylated DNA
Hadley D. Sikes, Brooke E. Tam, Ki-Joo Sung, Yining Hao, Dana B. Dabbousi

02:10 PM

(541e) Effective Physiological and Anatomical Parameters on Fractional Fluid Reserve (FFR) of Coronary Artery Stenosis
R. Eric Berson, Javad Hashemi, Shahab Ghafghazi

02:35 PM

(541f) Analysis of Carbonyl Compounds in Exhaled Breath for Identificationf of LUNG Cancer Biomarkers
Qi Li, Mingxiao Li, Michael H. Nantz, Xiao-An Fu